H3P23 |
|
H3 histone pseudogene 23
|
|
|
0.443 |
0.769 |
HGF |
P14210
|
hepatocyte growth factor
|
Enzyme
|
1.00 |
0.374 |
0.885 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
HMGB1 |
P09429
|
high mobility group box 1
|
Nucleic acid binding
|
0.82 |
0.368 |
0.923 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
IFI27 |
P40305
|
interferon alpha inducible protein 27
|
|
1.1E-02 |
0.437 |
0.769 |
IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL2 |
P60568
|
interleukin 2
|
|
0.48 |
0.336 |
0.885 |
KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
KRT19 |
P08727
|
keratin 19
|
|
4.3E-03 |
0.460 |
0.731 |
MCL1 |
Q07820
|
MCL1 apoptosis regulator, BCL2 family member
|
Signaling
|
0.96 |
0.430 |
0.808 |
MGMT |
P16455
|
O-6-methylguanine-DNA methyltransferase
|
|
1.2E-07 |
0.412 |
0.885 |
MICA |
Q29983
|
MHC class I polypeptide-related sequence A
|
|
5.0E-03 |
0.473 |
0.846 |
MIR27A |
|
microRNA 27a
|
|
|
0.466 |
0.846 |
MTA1 |
Q13330
|
metastasis associated 1
|
Nucleic acid binding
|
1.00 |
0.547 |
0.692 |
MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
MTOR |
P42345
|
mechanistic target of rapamycin kinase
|
Kinase
|
1.00 |
0.343 |
0.885 |
MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |